证券代码：301108 证券简称：洁雅股份 公告编号：2023-060 铜陵洁雅生物科技股份有限公司 关于与专业投资机构共同投资的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、投资概述 铜陵洁雅生物科技股份有限公司（以下简称 "公司"）于2023年10月9日召 开第五届董事会第十四次会议和第五届监事会第十二次会议，于2023年10月25 日召开2023年第二次临时股东大会，审议通过《关于与专业投资机构共同投资的 议案》，同意公司作为有限合伙人以自有资金出资人民币8,000万元与专业投资 机构厦门琢石明玉私募基金管理有限公司、铜陵高新科技发展有限公司及自然人 彭松投资设立铜陵市雅石共赏美妆健康股权投资合伙企业（有限合伙）（以下简 称"雅石共赏"或"合伙企业"，暂定名，最终名称以市场监督管理机构登记核 定的为准），占合伙企业认缴出资总额的78.4314%。具体内容详见公司于2023 年10月10日在巨潮资讯网（http://www.cninfo.com.cn）上披露的《关于与专业投 资机构共同投资的公告》（公告编号：2023-048）。 二、投资进 ...

证券代码：301108 证券简称：洁雅股份 铜陵洁雅生物科技股份有限公司 投资者关系活动记录表 编号：2023-026 特定对象调研 分析师会议 投资者关系 □媒体采访 □业绩说明会 活动类别 □新闻发布会 □路演活动 现场参观 其他 线上会议 【信达证券】：汲肖飞、李俏；【银华基金】：贾鹏、郭思捷； 参与单位名称 【天弘基金】：吕俏；【建投资管】：张燕；【华安资产】：陈 及人员姓名 玥昕；【诚旸投资】：尹竞超。 时间 2023年11月 24日 15:00-16:00 铜陵市狮子山经济开发区地质大道528号 地点 铜陵洁雅生物科技股份有限公司会议室 副总经理、董事会秘书：胡能华 上市公司接待 董事、财务总监：杨凡龙 人员姓名 证券事务代表：徐文丽 一、问答环节： ...

证券代码：301108 证券简称：洁雅股份 公告编号：2023-059 铜陵洁雅生物科技股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 近日，公司使用部分闲置募集资金 10,000 万元进行了现金管理，现将具体 情况公告如下： 铜陵洁雅生物科技股份有限公司（以下简称"公司"）于2023年1月13日召 开第五届董事会第九次会议和第五届监事会第八次会议，于2023年2月2日召开 2023年第一次临时股东大会，审议通过了《关于使用部分闲置募集资金进行现金 管理的议案》，同意在确保不影响募集资金投资项目建设和公司正常经营的前提 下，使用额度不超过人民币6亿元的部分闲置募集资金（含超募资金）进行现金 管理，用于购买安全性高、流动性好、期限不超过12个月的短期投资理财产品。 使用期限自股东大会审议通过之日起12个月内有效。在上述额度和期限内，资金 可循环滚动使用，并授权董事长在上述额度和期限范围内行使相关投资决策权并 签署相关文件，公司财务部门具体办理相关事宜。具体内容详见公司于2023年1 月14日在巨潮资讯 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2023-058 铜陵洁雅生物科技股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）于2023年10月9日召 开第五届董事会第十四次会议，于2023年10月25日召开2023年第二次临时股东大 会，审议通过了《关于增加公司经营范围及修订〈公司章程〉并办理工商变更登 记的议案》，同意增加公司经营范围及修订《公司章程》。具体内容详见公司于 2023年10月10日在巨潮资讯网（www.cninfo.com.cn）披露的《关于增加公司经营 范围及修订〈公司章程〉并办理工商变更登记的公告》（公告编号：2023-047）。 类型：股份有限公司（上市、自然人投资或控股） 法定代表人：蔡英传 注册资本：捌仟壹佰贰拾万玖仟捌佰壹拾捌圆整 成立日期：1999年08月31日 营业期限：1999年08月31日至长期 住所：安徽省铜陵市狮子山经济开发区地质大道528号 经营范围：一般项目：新材料技术研发；日用化学产品制造；卫生用品和 ...

证券代码：301108 证券简称：洁雅股份 铜陵洁雅生物科技股份有限公司 投资者关系活动记录表 编号：2023-025 特定对象调研 分析师会议 投资者关系 □媒体采访 □业绩说明会 活动类别 □新闻发布会 □路演活动 现场参观 其他 电话会议 【财通证券】：余剑秋、王宇璇；【平安养老】：唐宋媛；【广 参与单位名称 银理财】：王未红；【嘉实基金】：李不凡；【上海六禾资管】： 及人员姓名 韩靖；【东证融汇】：张超凡；【中信建投（资管）】：刘岚； 【中金公司】：惠普；【兴业证券】：侯宜芳。 时间 2023年10月30日 16:00-16:20 铜陵市狮子山经济开发区地质大道528号 地点 铜陵洁雅生物科技股份有限公司证券部办公室 副总经理、董事会秘书：胡能华 上市公司接待 董事、财务总监：杨凡龙 人员姓名 证券事务代表：徐文丽 ...

Financial Performance - The company's revenue for Q3 2023 was ¥167,752,346.77, representing a 1.00% increase compared to the same period last year, but a 14.91% decrease year-to-date[5] - Net profit attributable to shareholders for Q3 2023 was ¥28,475,169.82, down 28.41% year-on-year, and down 27.42% year-to-date[5] - The basic earnings per share for Q3 2023 was ¥0.35, a decrease of 28.57% compared to the same period last year[5] - Operating revenue for the current period was ¥447,270,982.69, down from ¥525,642,120.12 in the previous period, reflecting a decline of approximately 14.85%[20] - The net profit for Q3 2023 was CNY 92,961,537.75, a decrease of 28% compared to CNY 128,931,590.45 in the same period last year[22] - The company recorded a profit before tax of CNY 106,196,773.60, down from CNY 148,216,803.21 in the same quarter last year, representing a decrease of approximately 28.4%[22] - The company’s operating profit was CNY 106,023,943.93, a decline of 29.2% compared to CNY 149,882,426.89 in the previous year[22] - The company’s total comprehensive income for the period was CNY 92,961,537.75, down from CNY 128,931,590.45 in the same period last year, reflecting a decrease of approximately 28%[23] Cash Flow and Liquidity - The company reported a significant decrease in cash flow from operating activities, with a net cash flow of ¥91,361,954.70, down 63.62% year-to-date[5] - The cash flow from operating activities was CNY 91,361,954.70, significantly lower than CNY 251,099,152.55 in the previous year, indicating a decrease of about 63.7%[24] - The total cash and cash equivalents at the end of the period were CNY 323,838,149.50, a decrease from CNY 1,164,664,376.32 at the end of the previous year, indicating a reduction of about 72.1%[25] - Cash and cash equivalents decreased to ¥338,732,363.54 from ¥1,004,571,421.92, indicating a significant reduction in liquidity[17] Assets and Liabilities - Total assets as of September 30, 2023, were ¥2,118,914,217.24, reflecting a 2.52% increase from the end of the previous year[5] - The company’s total equity increased to ¥1,842,809,494.13 from ¥1,779,133,963.66, reflecting a growth of approximately 3.56%[19] - Total liabilities decreased to ¥276,104,723.11 from ¥287,729,528.80 at the start of the year, indicating a reduction in financial obligations[19] - The company’s financial liabilities related to lease obligations decreased to ¥9,016,855.13 from ¥12,765,069.41, indicating improved management of long-term liabilities[19] - The company experienced a 14.91% decline in revenue year-to-date, primarily due to decreased sales of disinfectant wet wipes[10] Investment and Expenses - Investment income increased by 563.12% year-to-date, amounting to ¥12,566,148.74, attributed to higher returns from financial products[10] - The company’s research and development expenses for Q3 2023 were ¥17,810,692.48, a decrease of 6.72% compared to the same period last year[10] - Research and development expenses were ¥17,810,692.48, slightly lower than ¥19,093,584.45 in the previous period, indicating a focus on cost management[20] - Cash payments for investments increased by 37.64% to CNY 1,069,397,109.14, mainly due to the purchase of financial products with idle funds[11] - Cash payments for fixed assets, intangible assets, and other long-term assets rose by 189.25% to CNY 69,511,383.02, attributed to increased project payments[11] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,698, with no preferred shareholders[12] - The largest shareholder, Chao Yingchuan, holds 52.88% of the shares, totaling 42,946,052 shares[12] Strategic Initiatives - The company signed a strategic cooperation framework agreement with Xiamen Zhuoshi Mingyu Private Fund Management Co., Ltd. on July 14, 2023, to promote business cooperation[14] - The company approved the grant of 100,000 restricted stocks at a price of CNY 18.99 per share to eligible incentive objects on July 21, 2023[15] - The company agreed to invest CNY 26 million to acquire a 20% stake in Saide Li (Jiujiang) Fiber Co., Ltd. on July 25, 2023[15]

Financial Performance - The company's operating revenue for Q3 2023 was CNY 167,752,346.77, representing a 1.00% increase year-on-year, while the revenue for the year-to-date period decreased by 14.91% to CNY 447,270,982.69[5]. - The net profit attributable to shareholders for Q3 2023 was CNY 28,475,169.82, down 28.41% year-on-year, and the year-to-date net profit decreased by 27.42% to CNY 93,575,901.93[5]. - The basic earnings per share for Q3 2023 was CNY 0.35, a decrease of 28.57% compared to the same period last year, with a year-to-date figure of CNY 1.15, down 27.67%[5]. - Total revenue for the third quarter of 2023 was CNY 447,270,982.69, a decrease of 15% compared to CNY 525,642,120.12 in the same period last year[20]. - The net profit for Q3 2023 was CNY 92,961,537.75, a decrease of 28% compared to CNY 128,931,590.45 in the same period last year[22]. - The total comprehensive income for the period was CNY 92,961,537.75, compared to CNY 128,931,590.45 in the same period last year, showing a decrease of about 28%[23]. Assets and Liabilities - Total assets as of September 30, 2023, were CNY 2,118,914,217.24, reflecting a 2.52% increase from the end of the previous year[5]. - The company's total assets as of September 30, 2023, amounted to CNY 2,118,914,217.24, an increase from CNY 2,066,863,492.46 at the beginning of the year[19]. - Current assets totaled CNY 1,580,758,075.92, showing a slight increase from CNY 1,515,435,496.23 at the start of the year[18]. - The total liabilities decreased from CNY 287,729,528.80 to CNY 276,104,723.11, indicating a reduction of approximately 4%[19]. - The equity attributable to the parent company increased to CNY 1,842,463,858.31 from CNY 1,779,133,963.66, reflecting a growth of about 3.6%[19]. Cash Flow - The company's cash flow from operating activities for the year-to-date period was CNY 91,361,954.70, down 63.62% compared to the previous year[5]. - The net cash flow from operating activities was CNY 91,361,954.70, significantly lower than CNY 251,099,152.55 in the previous year, indicating a decrease of about 63.7%[24]. - The company reported a net cash outflow from investing activities of CNY -697,734,381.37, compared to CNY -371,668,222.49 in the same period last year, reflecting an increase in investment expenditures[25]. - The cash and cash equivalents at the end of the period were CNY 323,838,149.50, down from CNY 1,164,664,376.32 at the end of the previous year, indicating a significant reduction in liquidity[25]. Investment and Expenses - The company reported a significant increase in trading financial assets, which rose by 40.13% to CNY 421,251,174.73 due to increased investment in financial products[10]. - Research and development expenses for the year-to-date period were CNY 17,810,692.48, a decrease of 6.72% from the previous year[10]. - Cash paid for fixed assets, intangible assets, and other long-term assets rose to CNY 69.51 million, reflecting a 189.25% increase attributed to higher project payments[11]. - Investment cash payments surged to CNY 1.07 billion, marking a 137.64% increase as the company invested more idle funds in financial products[11]. - The company reported an investment income of CNY 12,566,148.74 for the quarter, significantly higher than CNY 1,895,000.00 in the previous year[20]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was not disclosed, but the top shareholder, Cha Yingchuan, holds 52.88% of shares[12]. - The top ten shareholders include various entities, with the largest being Cha Yingchuan, holding 42,946,052 shares[12]. Strategic Initiatives - The company signed a strategic cooperation framework agreement with Xiamen Zhuoshi Mingyu Private Fund Management Co., Ltd. on July 14, 2023, to promote business collaboration[14]. - The company approved the grant of 100,000 restricted stocks at a price of CNY 18.99 per share to eligible incentive targets on July 21, 2023[15]. - The company agreed to invest CNY 26 million to acquire a 20% stake in Saide Li (Jiujiang) Fiber Co., Ltd. on July 25, 2023[15].

铜陵洁雅生物科技股份有限公司 证券代码：301108 证券简称：洁雅股份 公告编号：2023-054 1、审议通过《关于<公司 2023 年第三季度报告>的议案》 经审议，公司董事会认为：公司《2023 年第三季度报告》真实反映了公司 2023 年第三季度的财务状况和经营成果，符合法律、行政法规、中国证监会和 深圳证券交易所的相关规定，报告内容真实、准确，完整，不存在任何虚假记载、 误导性陈述或者重大遗漏。 具体内容详见公司同日披露于巨潮资讯网（http://www.cninfo.com.cn）的 《2023 年三季度报告》。 表决结果：9 票同意，0 票反对，0 票弃权。 第五届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 铜陵洁雅生物科技股份有限公司（以下简称"公司"）第五届董事会第十五 次会议于 2023 年 10 月 27 日以现场结合通讯方式召开，本次会议的通知已于 2023 年 10 月 17 日通过电子邮件的方式送达全体董事。本次会议应出席董事 9 人，实 际出席董事 9 人（其中独立董事何文 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2023-055 铜陵洁雅生物科技股份有限公司 表决结果：3 票同意，0 票反对，0 票弃权。 三、备查文件 第五届监事会第十三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 铜陵洁雅生物科技股份有限公司（以下简称"公司"）第五届监事会第十三 次会议于 2023 年 10 月 27 日以现场结合通讯方式召开。会议通知于 2023 年 10 月 17 日以电子邮件方式发出。本次监事会应出席监事 3 人，实际出席监事 3 人 （其中监事俞彦诚先生以通讯表决的方式出席）。会议由公司监事会主席卢云凤 女士主持。本次监事会会议的召开符合《中华人民共和国公司法》等有关法律、 行政法规、部门规章、规范性文件及《公司章程》的规定。 二、监事会会议审议情况 经与会监事认真审议，形成如下决议： 1、审议通过《关于<公司 2023 年第三季度报告>的议案》 经审议，公司监事会认为：公司《2023 年第三季度报告》真实反映了公司 2023 年第三季度的财务状况和经营成果，符合法律、行政法规、 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2023-053 铜陵洁雅生物科技股份有限公司 2023年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东大会未出现否决议案的情形。 2. 本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开情况 1、会议召开时间 （1）现场会议召开时间：2023 年 10 月 25 日（星期三）下午 14:00。 （2）网络投票时间：2023 年 10 月 25 日（星期三）。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2023 年 10 月 25 日上午 9:15-9:25，9:30-11:30，下午 13:00-15:00；通过深圳证券交易所互 联网投票系统（http://wltp.cninfo.com.cn）投票的时间为 2023 年 10 月 25 日上午 9:15 至下午 15:00 期间的任意时间。 2、会议召开地点：安徽省铜陵市狮子山经济开发区地质大道 528 号铜陵洁 雅生物科技股份有限公司会议室。 3、会议召开方式：本次股东 ...